Systemic therapies for pediatric atopic dermatitis: A review for the primary care physician

Pediatric Annals

Volumn 38, Issue 7, 2009, Pages 380-387

  Shaw, Maren G ^a   Burkhart, Craig N ^a   Morrell, Dean S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CEFALEXIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DIPHENHYDRAMINE; DOXYCYCLINE; EMOLLIENT AGENT; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 11; LEFLUNOMIDE; MEPOLIZUMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; OPIATE ANTAGONIST; PHOSPHODIESTERASE INHIBITOR; PIMECROLIMUS; PREDNISONE; PROPYLTHIOURACIL; RITUXIMAB; TACROLIMUS; THALIDOMIDE; THYMOPENTIN; UNINDEXED DRUG; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; DRUG DERIVATIVE; GLUCOCORTICOID; IMMUNOLOGIC FACTOR; MYCOPHENOLIC ACID;

ACANTHOSIS NIGRICANS; ACNE; ALOPECIA; ANAPHYLAXIS; ANEMIA; APPETITE; ARTHRALGIA; ASEPTIC MENINGITIS; ATOPIC DERMATITIS; B CELL LYMPHOMA; BODY WEIGHT; BONE NECROSIS; BRAIN PSEUDOTUMOR; CATARACT; CHILDHOOD DISEASE; CHILL; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG COST; DYSURIA; ECZEMA; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; EXCITABILITY; FATIGUE; FEVER; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GLAUCOMA; GROWTH INHIBITION; HEADACHE; HEART ARRHYTHMIA; HERPES ZOSTER; HUMAN; HYPERESTHESIA; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPERTRICHOSIS; HYPOTENSION; INFECTION RISK; INSOMNIA; INTESTINE PERFORATION; KAPOSI SARCOMA; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER TOXICITY; LUNG FIBROSIS; LYMPHOMA; MACULOPAPULAR RASH; MALAISE; MOON FACE; MULTIPLE ORGAN FAILURE; MYALGIA; MYOPATHY; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; OFF LABEL DRUG USE; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PANCYTOPENIA; PARESTHESIA; PARONYCHIA; PATIENT MONITORING; PEPTIC ULCER; PHOTOTHERAPY; PHOTOTOXICITY; PNEUMONIA; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRURITUS; PSEUDOMEMBRANOUS COLITIS; PUSTULAR PSORIASIS; PYURIA; REVIEW; RIGOR; SECONDARY INFECTION; SERUM SICKNESS; SHOCK; SIDE EFFECT; SKIN BURNING SENSATION; SKIN CANCER; SKIN CARCINOMA; SOMNOLENCE; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STOMATITIS; STRIA; SUICIDAL IDEATION; SYSTEMIC THERAPY; TACHYCARDIA; TERATOGENICITY; THROMBOCYTOPENIA; TINNITUS; TREATMENT OUTCOME; TREMOR; URINARY FREQUENCY; URTICARIA; VASCULITIS; VOMITING; WEAKNESS; WOUND HEALING IMPAIRMENT; ALGORITHM; CHILD; HOSPITALIZATION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PRESCHOOL CHILD; PRIMARY HEALTH CARE;

ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATITIS, ATOPIC; EMOLLIENTS; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; INFANT; INFUSIONS, INTRAVENOUS; INTERFERON-GAMMA; METHOTREXATE; MYCOPHENOLIC ACID; PHOTOTHERAPY; PRIMARY HEALTH CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70149088776     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090622-08     Document Type: Review

References (20)

1. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. 1. J Allergy Clin Immunol. 1999;103(1 Pt 1):125-138. (Pubitemid 29063202)
2. Borchard KL, Orchard D. Systemic therapy of paediatric atopic dermatitis: an update. Australas J Dermatol. 2008;49(3):123-134; quiz 135-136.
3. BuBmann C, Bieber T, Novak N. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges. 2009;7(3):205-219. [Article in English, German]
4. Schmitt J, Schäkel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol. 2007;87(2):100-111.
5. Lipozencixc J, Wolf R. Atopic dermatitis: an update and review of the literature. Dermatol Clin. 2007;25(4):605-612, x.
6. Dohil MA, Eichenfield LF. A treatment approach for atopic dermatitis. Pediatr Ann. 2005;34(3):201-210.
7. Ellis C, Luger T, Abeck D, Allen R, et al; ICCAD II Faculty. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003;148 Suppl 63:3-10.
8. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol. 2004;50(3):391-404.
9. Wolverton SE. Comprehensive Dermatologic Drug Therapy. 2nd ed. Philadelphia, PA: Elsevier; 2007:391-404.
10. Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20(1):71-77.
11. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methytransferase activity for moderate-to-severe atopic eczema: a double blind, randomized controlled trial. Lancet. 2006;367(9513):839-846.
12. Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double blind, placebo-controlled, crossover trial. Br J Dermatol. 2002;147(2):324-330.
13. Kuanprasert N, Herbert O, Barnetson RS. Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine. Australas J Dermatol. 2002; 43(2):125-127.
14. Murphy LA, Atherton D. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol. 2002;147(2):308-315.
15. Berth-Jones J, Finley AY, Zaki I, et al. Cyclosporine in severe childhood atopic dermatitis: A multicenter study. J Am Acad Dermatol. 1996;34(6); 1016-1021. (Pubitemid 26170768)
16. Bunikowski R, Staab D, Kussebi F, et al. Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: Clinical and immunological effects. Pediatr Allergy Immunol. 2001;12(4):216-223.
17. Harper JI, Ahmed I, Barclay G, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000;142(1);52-58.
18. Heller M, Shin HT, Orlow SJ, Schaffer JV. Mycophenolate mofetil for sever childhood atopic dermatitis: experience in 14 patients. Br J Dermatol. 2007;157(1):127-132.
19. Hanifin JM, Schneider LC, Leung DY, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993;28(2 Pt 1):189-197.
20. Noh G, Lee KY. Intravenous immune globulin therapy in steroid-resistant atopic dermatitis. J Korean Med Sci. 1999;14(1):63-68.